For instance, BC cell line models have been shown to carry activating mutations in Src kinases, which also modulate STAT3 and its effect on proliferation [288,289,290], and anti-STAT3 strategies has been shown to reduce tumour growth in animal studies [291]. Here, STAT3 is linked to breast cancer.